BIOFLOW-III Austria Satellite Registry
NCT01667016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305
Last updated 2017-09-28
Summary
This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
Sponsors & Collaborators
-
Biotronik Vertriebs-GmbH
lead INDUSTRY
Principal Investigators
-
Thomas Neunteufl, Prof. Dr. · Universitaetsklinik fuer innere Medizin II, Vienna
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-12-31
Countries
- Austria
Study Locations
More Related Trials
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
BIOFLOW III Satellite-Italy Orsiro Stent System
NCT02028728 ·Status: COMPLETED
-
BIOFLOW-III Canada Satellite Registry
NCT01880242 ·Status: COMPLETED
-
BIOFLOW III Asia Registry Orsiro Stent System
NCT01941290 ·Status: COMPLETED
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630 ·Status: RECRUITING ·Phase: NA
-
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
NCT01651390 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold
NCT02066623 ·Status: COMPLETED
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-china Post-marketing Study (BIOTRONIK)
NCT05667285 ·Status: TERMINATED
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study
NCT04612179 ·Status: COMPLETED
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
Economic Evaluation German Drug-Eluting Stent Registry
NCT00866398 ·Status: COMPLETED
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
NCT01443104 ·Status: COMPLETED ·Phase: NA
-
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
NCT01760083 ·Status: COMPLETED ·Phase: NA
-
First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions
NCT01214148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2